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Abstract
Background: Pertussis is a potentially serious respiratory illness characterized by cough of exceptionally long
duration of up to approximately100 days. While macrolide antibiotics are an effective treatment, there is an
ongoing debate whether they also shorten the length of cough symptoms. We investigated whether public health
surveillance data for pertussis, in which cases are identified at diagnosis, are potentially affected by selection bias
and the possible consequences for reported cough duration.
Methods: Data on 4,794 pertussis cases reported during 2000–2010 were extracted from the Michigan Disease
Surveillance System, a statewide, web-based communicable disease reporting system, to specifically investigate
increased duration of cough observed in pertussis patients with delayed initial healthcare visit. A simulated
population of cases was derived from the observed surveillance data and truncated week-by-week to evaluate the
effects of bias associated with stratification on timing of antibiotics.
Results: Cases presenting for medical evaluation later in the clinical course were more likely to have experienced
delayed antibiotic therapy and longer average cough duration. A comparable magnitude of increasing cough
duration was also observed in the simulated data. By stratifying on initial medical visit, selection bias effects based
on timing of healthcare visit were demonstrated.
Conclusions: Stratifying or controlling for the timing of the initial case identification and accompanying antibiotic
treatment can create artificial patterns of observed cough duration. In surveillance data, differences in symptom
duration may arise from selection bias and should not be presumed to be related to early antibiotic treatment.
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Background
Pertussis, caused by the bacterium, Bordetella pertussis,
and clinically characterized by a uniquely prolonged
cough, represents a potentially serious respiratory illness
that has experienced recent increases in incidence levels
not observed in the U.S. since the 1950′s [1]. The U.S.
Centers for Disease Control and Prevention (CDC) con-
ducts ongoing monitoring of pertussis cases through
state-based public health surveillance, and has utilized a
pertussis case definition requiring a minimum 14-day
cough, plus the presence of at least one of the following
cough attributes: post-inspiratory whoop, coughing par-
oxysms, or post-tussive vomiting [2]. The pathology of
cough symptoms is not well understood, but appears to
be the result of toxin-mediated virulence factors of B.
pertussis infection [3].
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Treatment of pertussis with macrolide antibiotics re-
duces the risk of transmission by effectively eliminating
the pathogen from patients in less than 3 days [4, 5].
This decreased risk of transmission is the primary rea-
son for antibiotic therapy, both in cases and in exposed
individuals. However, whether or not the timely use of
antibiotics shortens cough duration and the clinical
course of disease continues to be debated. While the
CDC pertussis treatment bulletin maintains that anti-
biotic use results in a shorter course of disease [6], a
number of studies that include case follow-up until ces-
sation of coughing show no effect of antibiotic therapy
on cough duration, even when antibiotics (like the
macrolide, azithromycin) are prescribed prophylactically,
that is before the onset of cough [4, 7–10].
Public health surveillance for pertussis typically identi-
fies cases at the point that an individual seeks medical
attention for a cough, which is the dominant clinical fea-
ture. However, healthcare seeking behavior for pertussis is
undoubtedly affected by both the severity and duration of
symptoms, including cough. This complicates analyses,
because stratifying on a variable within the causal pathway
between the exposure and outcome can induce a care-
seeking bias. For example, if adult patients wait twice as
long as children to seek medical care for an illness and the
diagnostic sensitivity is associated with length of illness,
then children will be over-represented in the surveillance
when compared to the population of ill persons. Control-
ling for (or stratifying on) the timing of the medical visit
makes it appear that age has an effect on diagnostic sensi-
tivity, when this may be due entirely to differences in
care-seeking behavior. Since passive surveillance data
identifies cases who choose to go for medical care, the
identified cases may not represent all infections in the
population at large, and care-seeking behavior creates an
important source of selection bias.
Stratifying pertussis cases based on the timing of the
initial medical visit may also create an unintentional
case-exclusion bias, as cases who delay the initial visit
are under-represented in the data. Indeed, they may be
less likely to seek care at all and, therefore, remain un-
detectable through clinical-or laboratory-based surveil-
lance. This exclusion of milder infections from the
surveillance database becomes more pronounced among
cases that present at later stages; especially around the
time the illness begins to resolve. As a result of this form
of selection bias, cases who delay the initial medical
evaluation appear to have a more prolonged clinical
presentation. Studies using public health surveillance
data rarely consider the potential impact of care-seeking
selection bias or case-exclusion bias and, thereby, can
contribute to a mistaken impression that earlier treat-
ment shortens cough duration [11–13]. This purported
effect is magnified when accompanied by incomplete
reporting of the outcome, such as cough duration in
pertussis cases.
In this analysis, we compared the week-to-week
differences in mean cough duration in the observed
surveillance data. Cases present in a variety of temporal
sequences and thereby enter into surveillance reporting
in ways that may contain bias. The epidemiological pat-
terns of cases were considered with regard to when they
started symptomatic coughing, and when a health-care
visit and drug therapy was begun (Fig. 1). In addition to
summarizing the observed data, we used a novel simula-
tion approach to create a theoretical data set and com-
pared how stratification by timing of first physician visit
(considered to be first antibiotic prescription) would
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Fig. 1 Sample pertussis case clinical histories, to illustrate data
limitations, biases and truncation. These six cases are illustrative of
the general timeline of symptom development and clinical care.
Time zero is the day of cough onset. Some cases seek medical
attention because of a potential exposure (Cases 5 and 6). While
both receive antibiotics prior to cough onset, but only case 6
received truly prophylactic treatment. However, this analysis cannot
reliably distinguish between these cases in the prophylactic group
of observed cases. The cough lengths of such estimates are
included in the observed estimates. However, the theoretical analysis
cannot distinguish any prophylactic cases from those who received
medical treatment in Week + 1 (Case 1). The analysis of this paper
created a dataset that replicated the distribution of cough duration
(black lines) based on the mean and standard deviation of the
natural log transformed surveillance data. The date of drug
treatment is our proxy for first medical visit, and is the potential
source of bias we are testing as cases are both identified and
subsequently stratified on this time point. By calculating the mean
of the theoretical distribution we estimated the average cough for
anyone who could visit the doctor in the first week of cough. By
excluding cases, we can determine who is still eligible to have their
first drug treatment in Week + 2. Therefore we must exclude all
individuals who already sought care (Cases 1, 5 and 6); this is care-
seeking bias. Additionally individuals who have already stopped
coughing would also be excluded; this is case exclusion bias
(Case 0). This process of excluding cases with events to the left of
the cut-point is call left-truncation. By calculating the mean cough
length of everyone remaining in the theoretical population after
truncation, we can estimate the new mean duration of those who
are eligible to see the physician in Week + 2
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affect the theoretical mean of cough duration. This creates
a simulated population of ill-persons who are still cough-
ing, and therefore eligible for a first medical visit, and
theoretically are detectable by the surveillance system. We
then compared the week-to-week differences of the sur-
veillance data and the theoretical results to determine
whether the incremental increase in cough duration of
surveillance data could be explained by selection bias.
Methods
Data source
The study included cases of pertussis reported to the
Michigan Department of Health and Human Services
(MDHHS) during 2000 through 2010 as part of the
state’s routine surveillance for reportable communicable
diseases. All probable or confirmed pertussis case re-
cords were included if they met two criteria based on
the dates provided in the records: 1) a cough duration
could be calculated, and 2) duration of the cough at the
time of the first medical appointment could be estab-
lished. Probable cases of pertussis were those that met
standard clinical criteria, whereas confirmed cases also
included a positive laboratory test or were a close con-
tact of another laboratory-confirmed case. The first re-
ported date of antibiotic prescription was used as a
proxy for the initial healthcare visit. These data were
compared with a simulated data set that was generated
from characteristics of the observed cases.
Data simulation
The observed MDHHS data distribution was used to
simulate a theoretical data set using the RAND function
of SAS, which is a random-number function from a
pseudo-random number generator. We specified a simu-
lated sample of 5,000 cases, with a normal distribution
of cough duration, based on the mean and standard de-
viation (SD) of natural-log transformed values of cough
duration that were actually reported. The original cough
duration had a log-normal distribution. The simulated
data represent a theoretical population of ill persons.
The simulation population was left-truncated in week-
long increments, to exclude those whose cough resolved
prior to week of first healthcare visit; this mimics the ef-
fects of delaying healthcare. The dataset was successively
truncated (weeks were removed) at days 7, 14, 21 and
28, following cough onset. The retained data represents
the week-by-week distribution of individuals remaining
in the general ill population (illustrative examples in
Fig. 1). Following each of the four truncations, the mean
cough duration of the remainder of the population was
re-calculated. By removing everyone in the simulated
population whose cough resolves before day seven, for
example, only those who are still ill and eligible to visit a
physician in week 2 (days 7–13) remain (Fig. 1). The
simulated population analysis can neither describe the
effects of seeking medical care prior to coughing
(prophylactic treatment) nor abstaining from antibiotics.
Data analysis
The associations between the timing of the initial health-
care visit relative to cough onset and other disease char-
acteristics in the MDHHS data were tabulated. We then
compared the week-to-week differences within the
theoretical data to the observed results, to determine
whether the incremental increase in cough duration of
surveillance data could be explained by selection bias.
A comparison is also made to determine whether there
were significant differences between cases in week one
against later weeks, week 0 data was excluded. Categor-
ical comparisons were made using a chi-squared test,
while comparisons of means were made using the
Satterthwaite T-test. All data management was con-
ducted using SAS version 9.2 (Cary, North Carolina,
USA). The data acquisition and analysis plan for this
study was approved by the Institutional Review Board
(IRB) of the MDHHS and subsequently deemed exempt
from review as secondary data analysis by the IRB of the
University of Michigan.
Results
There were 4,794 unique pertussis cases reported in
Michigan during 1 January, 2000 through 31 December,
2010, of which 3,365 (70.1 %) had information recorded
for both total cough duration and for duration of cough
at initial clinical evaluation (or initial medical appoint-
ment). Reported cough duration of cases averaged
32.1 days (standard deviation (SD) = 23.7). Of the re-
ported cases, 82.2 % were still coughing when the sur-
veillance report was finalized. Virtually all pertussis
cases (99.1 %) reported taking some type of antibiotic,
the most common of which were Clarithromycin/Azi-
thromycin (70.3 %), Erythromycin (14.6 %), and Amoxi-
cillin (6.5 %).
Cases presenting later in the clinical course of disease
for initial medical evaluation were experienced by defin-
ition delayed antibiotic therapy and also were more likely
to have a) longer average cough duration (difference =
9.8 days 95 % CI (7.9–11.6), Satterwaithe p-value < .01), b)
more accompanying cough attributes (difference = 5.4 %,
χ2 = 21.8, p < .01), and c) treatment specifically with
macrolide antibiotics (difference = 6.9 %, χ2 = 21.9, p < .01)
(Table 1). These associations were also observed when
stratifying by age (data not shown). However, cases who
were prescribed antibiotics prior to cough onset (Table 1,
Week 0), reported a mean cough duration of 28.7 days, al-
though ~20 % of these cases were still coughing when the
cough length was reported. This is cough duration was
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Table 1 Pertussis cough characteristic trends associated with initial medical visit (week of antibiotic prescription) and simulated findings
Week of antibiotic
prescription
Observed Percentage of records Observed days Simulated Daysa
Nb Coughing at final




(95 % CI) c
Cough duration
mean (95 % CI)
Mean differenced Cough duration
mean (95 % CI)
Mean differenced
0e 65 80.0 (70.0–90.0) 65.6 (52.7–76.6) 81.5 (71.8–81.2) 28.7 (24.8–32.5) N/A N/A N/A
1st 809 79.7 (76.9–82.5) 79.7 (76.0–81.7) 86.8 (84.4–89.1) 24.8 (23.4–26.1) −3.9 26.1 (25.6–26.5) N/A
2nd 1043 84.1 (81.9–86.3) 84.8 (81.9–86.3) 92.0 (90.3–93.6) 25.6 (24.6–26.5) 0.8 26.9 (26.4–27.3) 0.8
3rd 613 86.5 (83.7–89.2) 85.7 (82.0–87.7) 92.0 (89.9–94.2) 30.5 (29.2–31.9) 4.9 31.8 (31.3–32.3) 4.9
4th 341 83.9 (79.9–87.8) 89.6 (85.2–92.0) 92.7 (89.9–95.4) 34.8 (33.5–36.1) 4.3 38.8 (68.5–39.4) 7.0
5thf 494 76.1 (72.3–80.0) 89.2 (85.9–91.5) 92.7 (90.4–95.0) 58.3 (55.1–61.5) 23.5 46.1 (45.4–46.8) 7.3
CI confidence interval, N number
a Simulated cough duration (number of days) was calculated using a hypothetical population distribution and applying the observed Michigan pertussis case data from actual surveillance, then removing people
(left-truncating) 1 week at a time
b N refers only to the observed data. Some characteristics were not reported in all surveillance records, therefore N varies
c Cough attributes include cases having one or more of the following (proportion positive within the dataset): paroxysms (85.1 %), post-tussive vomiting (51.2 %), or whooping (37.0 %)
d The difference of the mean cough duration of cases with their first medical visit in the current week (same row) compared to the previous week (previous row)
e Week 0 cases had their first medical visit prior to the onset of cough, and received antibiotics prophylactically













similar to that observed among those whose initial visit
was in the first and second week of cough onset (Table 1).
The mean of the individual cough duration values was
26.6 days (95 % Confidence Interval (CI) 26.0–27.1).
Left-truncation of the simulated data showed that care-
seeking bias results in longer mean cough duration with
each successive week (Table 1). An average increase of 1
day of cough occurred between weeks 1 and 2, of 5 days
between weeks 2 and 3, and of 7 days per week thereafter.
This week-to-week analysis characterized the effects of
truncation, or delayed care seeking, on a theoretical popu-
lation independent of treatment, so that increasing cough
length was not a result of antibiotic therapy. Instead, it
would appear to be due to care-seeking bias. This care-
seeking bias effect, demonstrated via truncation, parallels
the difference in cough duration observed in the actual
MDHHS data over the first 5 weeks, when more than
three-quarters of cases sought medical care.
Discussion
The dramatic increase in pertussis cases nationally presents
an opportunity to develop more accurate characterization
of cases through well-designed public health surveil-
lance to better inform our understanding of risk and
the role of treatment on case detection and the course
of clinical disease [1]. Our study reveals that stratifying
surveillance detected pertussis cases by timing of the
initial medical visit creates the false impression of a
trend of increasing cough length, independent of anti-
biotic therapeutic effects. If antibiotics could effect a
shorter cough duration, then cases who sought medical
attention earliest in their course of illness should have
the shortest duration of cough. These would be those
cases who used antibiotics prophylactically, before a
cough began (Fig. 1, Cases 5 & 6). This was not evident
in our analysis, and also other data [13]. Care-seeking
bias would neither affect those cases who sought care
prior to cough onset [8], nor those who did not use an-
tibiotics [13], where the entire cough duration was re-
ported. The pertussis cases who received antibiotics
prophylactically (N = 65) were not of sufficient number
to support additional analysis and, therefore, a simula-
tion was conducted.
Our study aimed to evaluate whether care-seeking and
case-exclusion biases in the pertussis surveillance data
could explain the increased cough duration observed
when the cases are stratified on the date of antibiotics,
which is also the initial medical visit, and the point of in-
clusion in the dataset. Our examination of these selec-
tion biases demonstrated that truncation of a simulated
ill population, like stratification of surveillance data ac-
cording to the timing of antibiotics, produced similar
week-to-week increases in mean cough duration. This
suggests that the bias can be producing the longer mean
cough observed in successively later weeks of the sur-
veillance data.
Because the bias effects can account for the results of
stratification, the increasing cough lengths of those who
delay medical care is unlikely to be related to the specific
effects of antibiotic treatment, which is supported in the
literature [4, 7–10]. Perhaps cough duration is not
dependent on the length of exposure to the bacterium
and its toxins, but rather the extent of cellular damage
and the slow speed of cellular regeneration (ciliated epi-
thelial cells have a half-life of around 6 months) [14].
While the observed cases had a mean cough duration
of 26.6 days, a study limitation was that 82 % of cases
were reported as still coughing during the final surveil-
lance case report. Some studies of surveillance data
found a similar mean cough duration of around a month
[15, 16], but others found a median to persist up to 7
weeks [11, 13]. If the median duration is 7 weeks, then it
follows that the cases in our data set were followed for
less than 7 weeks, as only 20 % reported complete cessa-
tion of cough. This length of follow-up should be suffi-
cient for pertussis treatment and outbreak investigation.
While having complete cough duration data would in-
crease the mean duration of cough, it would not affect
the premise of the study, which examines the effects of
selection-bias or left-truncation on the mean cough dur-
ation of a theoretical population.
Conclusions
Pertussis cases reported at the time of diagnosis, as is
typical for public health surveillance, are subject to both
care-seeking and case-exclusion biases. Our analysis
demonstrates that the truncating simulation can account
for the incremental differences in cough duration ob-
served when pertussis cases are stratified according to
week of first medical visit (when antibiotics are pre-
scribed), therefore a selection bias exists. This bias can
largely explain the increase in cough duration observed
in surveillance data among patients who delay care, and
is more parsimonious than an explanation based on the
debated effects of antibiotic treatment.
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